February 04, 2019
Haynsworth Sinkler Boyd’s Jeff Stover has been re-elected to the executive committee for South Carolina Biotechnology Innovation Organization (SCBIO). Jeff has served on the Board of Directors for SCBIO since 2017.
According to a release from SCBIO, President and CEO Sam Konduros praised the Executive Committee noting, “With the critically important efforts we are undertaking to advance pharmaceuticals, life sciences R&D, biotech, med-tech, and the health IT industries in South Carolina, we require strong, expert leadership from across the state, fully integrating our business, education and economic development sectors. These diverse leaders who represent the width and breadth of our state and industry will effectively champion our vision of building the business of life sciences in South Carolina for years to come.”
SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.
Jeff’s practice focuses on intellectual property, including patent, copyright, trademark, trade secret, unfair competition and related matters for clients operating in a wide range of technologies, including manufacturers, technology companies and startups. He also has litigation experience in a wide range of substantive areas, including general business disputes, shareholder disputes, fraud and misrepresentation claims, fiduciary duty claims, insurance coverage and bad faith disputes, and other types of disputes on behalf of both plaintiffs and defendants.